Receive The Newest Study Notifications

Medway NHS Foundation Trust, part of the U.K.'s National Institute for Health Research Clinical Research Network Kent Surrey and Sussex (CRN KSS), announced they have joined the TriNetX global health research network in an effort to attract more clinical trials and...

The medical advisory board of the Pulmonary Fibrosis Foundation (PFF), the nation's leading patient education and advocacy organization representing the more than 200,000 Americans with pulmonary fibrosis (PF), has issued an updated statement on the use of stem...

Sound Pharmaceuticals (SPI) is pleased to announce the completion of study enrollment in its Phase 2b clinical trial involving Meniere's Disease (MD). MD is diagnosed by episodic vertigo, fluctuating hearing loss, and intermittent or constant tinnitus, and is thought...

Forendo Pharma, a clinical stage drug development company focusing on novel treatments in women's health, today announces that it has successfully completed Phase 1a study of FOR-6219, an HSD17B1 inhibitor for the treatment of endometriosis. The randomised,...

Cancer centers design strategies for including more racial and ethnic minorities in clinical trials Not one size fits all, and nowhere does that show up more than in the recruitment of racial and ethnic minorities into clinical trials, says Hollings Cancer Center...

A project is generally described as a temporary endeavor undertaken to create a unique product, service or result.  By nature of the definition, clinical trials fall under the project umbrella. It begins with initial protocol development and doesn't end until all...

NKMax America, a biotechnology company harnessing the power of the body's immune system through the development of Natural Killer (NK) cell therapies, announced today that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug (IND)...

Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announces a clinical update to the previously reported...

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated an open label clinical trial to evaluate once-daily compared to twice-daily oral dosing of CTP-543 in patients with alopecia areata. The trial is intended to inform the optimal dosing...

A team of researchers from the Department of Energy's Oak Ridge National Laboratory Health Data Sciences Institute have harnessed the power of artificial intelligence to better match cancer patients with clinical trials. The researchers were one of ten teams to...

NIH-sponsored ABATE study shows benefit for subset of hospitalized patients. New findings from a large, randomized clinical trial that compared two infection control techniques are already being incorporated into practice within the network of U.S. community hospitals...

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced that it intends to use its remote software update tool, the Tandem Device Updater, to resolve a Control-IQ technology software anomaly identified...

Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to treat gastrointestinal diseases with an initial focus on the development of RP-G28, a drug...

First-in-class SIRPα checkpoint inhibitor Discovered and validated on OSE's immune target discovery platform NANTES, France, March 05, 2019 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics(ISIN: FR0012127173; Mnémo: OSE), today announced authorization by the French National...

Presented at the World Immunotherapy Congress USA 2019 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (Immutep or the Company), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune diseases, today announced positive, more mature data...

Data from its First Pediatric Study are Anticipated in the Second Half of 2019 AOBiome Therapeutics, Inc. ("AOBiome"), a leading clinical-stage microbiome company focusing on the research and development of therapeutics for dermatological conditions, migraine,...

A new, first-of-its kind project from researchers at The University of Kansas Cancer Center aims to boost participation in urologic cancer clinical trials by partnering with community urologists. Clinical trials are research studies that involve people. Clinical...

Unique solution offers sponsors a streamlined approach to the global supply chain Almac Group announces Almac One™ - providing the first unified Clinical Trial Supply solution. This solution redefines the Clinical Supply Chain experience, creating a responsive...

Upcoming free, educational webinars from Xtalks Webinars will feature topics on clinical trials, clinical operations, drug discovery and development, food, laboratory technology, medical device manufacturing and supply chain and medical device safety and regulation....

This study is approved by Israel's Ministry of Health and will be conducted in two medical centers in Israel. The trial is expected to be completed as early as Q1 2020. Lipomedix, a clinical-stage, oncology-focused pharmaceutical company, involved in the development...